| Document Date: 2012-06-11 16:08:09
Open Document File Size: 88,56 KBShare Result on Facebook
City Ottawa / / Company Cochrane Adverse Effects Methods Group / Cochrane Hypertension Review Group / / Continent Americas / / Country Canada / / Currency USD / / / Facility The Cochrane Library / p.m. Sheraton Guildford Hotel / / IndustryTerm Treatment of periodontal disease / healthcare professionals / online repository / online prices / healthcare professionals feedback / online learning opportunities / lightweight device / healthcare professionals learning materials / free online trial / online training / Diabetes Gum disease treatment / health systems / online content / / MedicalCondition diabetes Home-based / PDA / necrotizing enterocolitis / schizophrenia / seizures / patent ductus arteriosus / pre-existing gum disease / stroke / diabetes / non-severe illness / Gum disease / heart attacks / diabetes mellitus / Rotavirus infection / Rotavirus infections / periodontal disease / / MedicalTreatment immunization / oral contraceptives / birth control / emergency contraception / contraception / vaccination / Exercise Therapy / / Organization World Health Organization / Canadian Cochrane Centre / Health Systems Evidence Service / American Health Organization / / Person Camille Viray / / / Position Author / / Product Ibuprofen / indomethacin / / ProvinceOrState Ontario / / Technology PDA / / URL http /
SocialTag |
< Volume 12 - June 2010 > In the News Cochrane Canada receives $9.6 Million in Funding from the Canadian Institutes of Health Research The Canadian Institutes of Health Research (CIHR) recently announced $9.6